Successful use and safety of secukinumab in psoriatic patients with periodontitis: A valid therapeutic option

Dermatol Ther. 2020 May;33(3):e13350. doi: 10.1111/dth.13350. Epub 2020 Apr 8.

Authors

Pina Brianti¹, Giovanni Paolino^{1

2}, Santo R Mercuri¹

Affiliations

¹ Unit of Dermatology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
² Clinica Dermatologica, Sapienza University of Rome, Rome, Italy.

PMID: 32232910
DOI: 10.1111/dth.13350

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Arthritis, Psoriatic*
Humans
Periodontitis*

Substances

Antibodies, Monoclonal, Humanized
secukinumab